ОБ ЭТОМ ПОДКАСТЕ 🔗
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries.
Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences.
Disclaimer
https://biobizbuzz.com/disclaimer/
Ведущие:
Частота обновления:
biweekly
Средняя продолжительность аудио:
26 minutes
Гостевые интервью
английский
объединенное Королевство
28 серий
с 1 мая 2025 г.
episodic
В ЭТОМ ПОДКАСТЕ 🔗
ПОСЛЕДНИЙ ЭПИЗОД 🔗
In this episode of BioBiz Buzz, your host Mike Ward explores a critical, but often underappreciated, driver of vision loss in retinal diseases; the breakdown of the blood–retina barrier (BRB). While anti-VEGF therapies have transformed outcomes in diabetic macular oedema (DME) and wet age-related m…
ПРЕДЫДУЩИЕ ЭПИЗОДЫ 🔗
In this episode of BioBiz Buzz, Mike Ward talks to Dr Sam Possemiers, founder and CEO of Belgium-based MRM Health, about what it really takes to turn the human gut microbiome into a bona fide drug modality. They trace the arc from crude faecal microbiota transplants and limited single-strain probio…
Targeted protein degradation has moved from elegant academic concept to one of the most closely watched frontiers in oncology, promising to drug the 80% of disease‑driving proteins that traditional inhibitors and even ADCs still struggle to reach. In this episode of BioBiz Buzz, host Mike Ward sits…
For years, the narrative was simple: if you wanted a multibillion-dollar biotech outcome, you built in Boston or the Bay Area. Gilead’s up to $5 billion acquisition of Munich-based Tubulis just blew that up.
In this episode, Mike Ward and Andera Partners’ Sofia Ioannidou go inside one of Europe’s …
Progress in developing safe and effective therapies for amyotrophic lateral sclerosis (ALS) has been painfully slow. It is caused by the death of motor neurons in the central nervous system and the spinal cord, which leads to a loss of control over voluntary muscle movement, near-total paralysis an…
What if an annual self-injection could silence your hidden cardiac risk instead of just lowering your LDL?
In this episode of BioBiz Buzz, Mike Ward sits down with David Solomon, CEO of Thalia Therapeutics, to unpack how a once-yearly RNA gene-silencing therapy targeting both lipoprotein(a) and PCS…
For more than three decades, transcription factors have been the great white whale of oncology drug discovery; tantalising, genetically validated, mechanistically central, and yet stubbornly out of reach. They sit at the heart of cancer biology, driving the gene expression programmes that allow tum…
Multiple myeloma remains the second-largest blood cancer globally with no cure, and despite recent breakthroughs in CAR-T and antibody therapies, patients continue to relapse, often losing the very antigens that therapies target. In this episode of BioBiz Buzz, host Mike Ward speaks with Dr. Chris …
In this episode of BioBiz Buzz, your host Mike Ward sits down with Dr. Jared Baeten, Senior Vice President for Clinical Development and Head of the Virology Therapeutic Area at Gilead Sciences, to explore how new data from CROI 2026 could signal the start of a new chapter in HIV treatment and preve…
2025 has been a seismic year for the pharmaceutical industry, a year of extremes where innovation superpowers emerge alongside spectacular collapses. In this special episode, BioBiz Buzz host Jo Shorthouse sits down with Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership at C…
Отказ от ответственности: Подкаст и иллюстрации, встроенные в эту страницу, взяты из https://biobizbuzz.com/, который является собственностью его владельца и не связан или не одобрен Listen Notes, Inc.
ПОИСКОВАЯ СИСТЕМА ПОДКАСТОВ
Вы можете использовать наш веб-сайт для поиска подкастов3,821,573и эпизодов195,380,247по людям, местам или темам.
Инвестиции в знания приносят наибольшую отдачу, поэтому я слушаю подкасты.
‐ Benjamin "Llamacorn" Franklin
ЗАЯВИТЬ О ПРАВАХ
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post объявления for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
интервью с подкастером...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
наш официальный аккаунт в X (бывший Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
ИЗМЕНИТЬ
Спасибо, что помогаете поддерживать базу подкастов актуальной.
